| Autor: |
Naylor PH; Department of Internal Medicine, Wayne State University, School of Medicine, Detroit, MI 48201, USA., Smith MR, Mutchnick MG, Naylor CW, Dosescu J, Skunca M, Moshier JA |
| Jazyk: |
angličtina |
| Zdroj: |
International journal of immunopharmacology [Int J Immunopharmacol] 1996 May; Vol. 18 (5), pp. 321-7. |
| DOI: |
10.1016/0192-0561(96)00032-x |
| Abstrakt: |
Thymosin alpha 1 (T alpha 1) is an immune modulatory peptide which has been evaluated in a variety of clinical trials. Although no in vivo adverse effects, including enhancement of tumor growth, have been noted, in vitro studies suggesting a role for T alpha 1 in cell growth have been reported. The studies presented in this report evaluated both exogenously added T alpha 1 and endogenously expressed T alpha 1 as factors which could either promote growth of tumor cells or induce transformation. No effect of exogenous T alpha 1 on cell growth was found. NIH-3T3 cells transfected with cDNA for the precursor ProThymosin alpha (Pro T alpha) expressed elevated levels of authentic T alpha 1 but did not demonstrate either enhanced proliferation in liquid culture or transformation as defined by the loss of contact inhibition or anchorage independent growth in soft agar. Thus these studies argue against the hypothesis that T alpha 1 is either an intracellular or extracellular growth promoter. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect